Incidence and disease burden of chemotherapy-induced peripheral neuropathy in a population-based cohort.
作者： Arya Shah , E Matthew Hoffman , Michelle L Mauermann , Charles L Loprinzi , Anthony J Windebank
关键词:
摘要: … risk factors for CIPN that have been reported previously, namely diabetes mellitus10 and age.11 This may be because these risk factors … findings of increased CIPN risk in patients who …
elsevier.com
sci-hub.se 参考文章(24)
Cassandra Johnson, Vernon S. Pankratz, Ana I. Velazquez, Jeremiah A. Aakre, Charles L. Loprinzi, Nathan P. Staff, Anthony J. Windebank, Ping Yang, Candidate pathway-based genetic association study of platinum and platinum–taxane related toxicity in a cohort of primary lung cancer patients Journal of the Neurological Sciences. ,vol. 349, pp. 124- 128 ,(2015) , 10.1016/J.JNS.2014.12.041
Doug E. Campos-Outcalt, Accuracy of ICD-9-CM codes in identifying reportable communicable diseases. American Journal of Medical Quality. ,vol. 5, pp. 86- 89 ,(1990) , 10.1177/0885713X9000500304
T. Torgersen, L. A. Rosseland, U. F. Malt, Coding guidelines for ICD-9 section on mental disorders and reliability of chart clinical diagnoses. Acta Psychiatrica Scandinavica. ,vol. 81, pp. 62- 67 ,(1990) , 10.1111/J.1600-0447.1990.TB06450.X
Augusta N. Uwah, Joan Ackler, John C. Leighton, Sherry Pomerantz, William Tester, The effect of diabetes on oxaliplatin-induced peripheral neuropathy. Clinical Colorectal Cancer. ,vol. 11, pp. 275- 279 ,(2012) , 10.1016/J.CLCC.2012.05.002
Marta Seretny, Gillian L Currie, Emily S Sena, Sabrina Ramnarine, Robin Grant, Malcolm R MacLeod, Leslie A Colvin, Marie Fallon, None, Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain. ,vol. 155, pp. 2461- 2470 ,(2014) , 10.1016/J.PAIN.2014.09.020
J. D. England, G. S. Gronseth, G. Franklin, R. G. Miller, A. K. Asbury, G. T. Carter, J. A. Cohen, M. A. Fisher, J. F. Howard, L. J. Kinsella, N. Latov, R. A. Lewis, P. A. Low, A. J. Sumner, Distal symmetric polyneuropathy: A definition for clinical research Report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation Neurology. ,vol. 64, pp. 199- 207 ,(2005) , 10.1212/01.WNL.0000149522.32823.EA
J. L. St Sauver, B. R. Grossardt, B. P. Yawn, L. J. Melton, J. J. Pankratz, S. M. Brue, W. A. Rocca, Data Resource Profile: The Rochester Epidemiology Project (REP) medical records-linkage system International Journal of Epidemiology. ,vol. 41, pp. 1614- 1624 ,(2012) , 10.1093/IJE/DYS195
R.K. Ramanathan, M.L. Rothenberg, A. de Gramont, C. Tournigand, R.M. Goldberg, S. Gupta, T. André, Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies Annals of Oncology. ,vol. 21, pp. 754- 758 ,(2010) , 10.1093/ANNONC/MDP509
Bryan P. Schneider, Fengmin Zhao, Molin Wang, Vered Stearns, Silvana Martino, Vicky Jones, Edith A. Perez, Tom Saphner, Antonio C. Wolff, George W. Sledge, William C. Wood, Nancy E. Davidson, Joseph A. Sparano, Neuropathy Is Not Associated With Clinical Outcomes in Patients Receiving Adjuvant Taxane-Containing Therapy for Operable Breast Cancer Journal of Clinical Oncology. ,vol. 30, pp. 3051- 3057 ,(2012) , 10.1200/JCO.2011.39.8446
Bruno Vincenzi, Anna Maria Frezza, Gaia Schiavon, Chiara Spoto, Raffaele Addeo, Vincenzo Catalano, Francesco Graziano, Daniele Santini, Giuseppe Tonini, Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV Supportive Care in Cancer. ,vol. 21, pp. 1313- 1319 ,(2013) , 10.1007/S00520-012-1667-5